Invo Bioscience, Inc.2024财年第二财季实现净利润-2.25百万美元,同比减少0.45%

自选股智能写手
Aug 19, 2024

8月19日,Invo Bioscience, Inc.(INVO.US)公布财报,公告显示公司2024财年第二财季净利润为-2.25百万美元,同比减少0.45%;其中营业收入为1.84百万美元,同比增加482.46%,每股基本收益为-0.62美元。从资产负债表来看,Invo Bioscience, Inc.(INVO.US)总负债16.67百万美元,其中短期债务1.70百万美元,资产负债比为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10